Prevalence of coronary artery disease before valvular surgery in patients with rheumatic valvular disease

Enver Atalar1, Hikmet Yorgun, Uğur Canpolat

  • 1Department of Cardiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Coronary Artery Disease
|October 31, 2012
PubMed

Insights

The prevalence of coronary artery disease (CAD) in patients with rheumatic valvular disease (RVD) is low overall. However, rheumatic aortic stenosis is linked to higher CAD rates, while aortic regurgitation shows a lower prevalence.

Area of Science:

  • Cardiology
  • Valvular Heart Disease
  • Coronary Artery Disease

Background:

  • Limited data exist on the association between rheumatic valvular disease (RVD) and coronary artery disease (CAD).
  • Investigating CAD prevalence in RVD patients undergoing valvular surgery is crucial.

Purpose of the Study:

  • To determine the prevalence of significant coronary artery disease (CAD) in patients with rheumatic valvular disease (RVD).
  • To explore the association between specific RVD types and CAD.

Main Methods:

  • Retrospective analysis of 1075 patients (61.2% women, mean age 53.2 years) who underwent coronary angiography before valvular surgery.
  • Data collected between January 2003 and May 2010.

Main Results:

  • Overall prevalence of significant CAD was 11.1%.
  • Significant CAD was more common in older patients with hypertension, smoking history, diabetes mellitus, and dyslipidemia.
  • Rheumatic aortic stenosis predicted higher CAD prevalence (OR 1.66), while aortic regurgitation showed an inverse association (OR 0.56).

Conclusions:

  • The prevalence of CAD in RVD patients is generally low.
  • Rheumatic aortic stenosis is associated with an increased prevalence of CAD.
  • Aortic regurgitation is associated with a lower prevalence of CAD.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...